Endogenous Endophthalmitis in the Inpatient Setting

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the rate of endogenous endophthalmitis in patients admitted to Stanford Hospital with a systemic infection and positive blood cultures, as this may improve the clinical care of this population of patients.

Clinical Trial Description

Some patients admitted to the hospital have blood-borne infections. Occasionally, these blood infections can end up inside the eye and cause an infection inside the eye (called endogenous endophthalmitis).

Prior to modern and rapid treatment of systemic infections, the rate of endogenous endophthalmitis was reported to be 37% in 1982. By 1997, the rate was reported to be 2.8%. This study aims to determine the rate of endogenous endophthalmitis at Stanford Hospital in the modern medical era in that our rates may be different as those reported in the literature. This potential difference may be a reflection of treatment protocols and antibiotics currently in use at Stanford Hospital. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Endophthalmitis

Clinical Trial Details

NCT number	NCT01323868
Study type	Observational
Source	Stanford University
Contact
Status	Completed
Phase	N/A
Start date	July 2010
Completion date	June 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04214821` - The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%	Phase 1/Phase 2
Completed	`NCT00461656` - Povidone-iodine Antisepsis for Strabismus Surgery	Phase 4
Completed	`NCT00136344` - Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery	N/A
Completed	`NCT04568213` - Hypochlorous Acid Disinfection Prior to Cataract Surgery	Phase 3
Terminated	`NCT01496794` - Endophthalmitis Cultures	N/A
Completed	`NCT00406913` - Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery	N/A
Recruiting	`NCT05079854` - Use Of Intracameral Moxifloxacin For Prophylaxis Of Open Globe Endophthalmitis	Phase 4
Recruiting	`NCT05432336` - Complex Ocular Infection, Optimization of Microbiological Diagnosis
Recruiting	`NCT02810587` - Endophthalmitis After Intravitreous Anti-VEGF Injections in Patients Receiving vs. Not Receiving Topical Antibiotics	N/A
Completed	`NCT00398658` - Prophylaxis of Acute Post-Traumatic Bacterial Endophthalmitis	Phase 4
Recruiting	`NCT04035369` - Endophthalmitis Post Intravitreal Injections	N/A
Not yet recruiting	`NCT03420820` - Concentrating on Antisepsis: 5% vs. 10% Povidone-Iodine Prior to Intravitreal Injection	N/A
Recruiting	`NCT06268561` - Ozurdex Endophtamitis Cohort, Prognostic Assessment at 12 Months
Withdrawn	`NCT00335231` - Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract Surgery	N/A
Not yet recruiting	`NCT03244072` - Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery	Phase 2/Phase 3
Completed	`NCT03363295` - Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis	Phase 4
Suspended	`NCT02590523` - Intracameral Antibiotic Safety Study	Phase 3
Terminated	`NCT02770729` - Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.	Phase 3
Not yet recruiting	`NCT02324166` - Cefazolin-Lidocaine Combination Solution to Reduce Antibiotic Pain	Phase 4
Completed	`NCT02595359` - Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis	Phase 2